About Bikram Singh
Form D filings for Nivagen Pharmaceuticals in 2017 list Bikram Singh as director.
Bikram Singh first appears on SEC filings in 2017.
Experience
This experience comes from SEC filings. The years are when the filings name Bikram Singh in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Bikram Singh works with at each company, as listed on that company's latest Form D.
Nivagen Pharmaceuticals, Inc. · Form D, Sep 14, 2017